← Open Payments lookup

SUKHPREET KAUR: Open Payments

NPI 1083951735 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$546 in 23 payments from 14 companies in 2025. Trend: 2023 $415 · 2024 $640 · 2025 $546

Food & beverage: $546
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.4$153
Fresenius USA Marketing, Inc.3$61
Alexion Pharmaceuticals, Inc.2$55
Otsuka America Pharmaceutical, Inc.2$38
Amgen Inc.2$36
SCPHARMACEUTICALS INC.2$36
GlaxoSmithKline, LLC.1$27
AKEBIA THERAPEUTICS INC1$27
Botanix SB Inc1$23
Travere Therapeutics, Inc.1$22

Products named: TARPEYO, VELPHORO, ULTOMIRIS, KRYSTEXXA, FUROSCIX, BENLYSTA, Vafseo, SOFDRA.

Industry payments across CA — which companies pay providers there.